RecruitingNCT07043166

Cardiovascular-Kidney-Metabolic Syndrome in Shanghai Zicitizens

Epidemiological Survey and Follow-up of Cardiovascular-Kidney-Metabolic Diseases Among Adults in Shanghai


Sponsor

Shanghai Changzheng Hospital

Enrollment

4,094 participants

Start Date

Jul 1, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

The main purpose of this study is to conduct follow-up assessments and update the cardiorenal outcomes among the STONE cohort that was established during 2016-2017. The secondary aim is to compare metabolic risk factors, metabolic disturbances, and clinically relevant metabolic outcomes between the follow-up period and the baseline assessment. The exploratory goal is to examine the relationships between changes in risk factors and clinical outcomes in the participants. The study is planned to begin in May 2025 and will finalize the data collection for the entire population by June 2026. During this time, participants will be categorized based on CKM staging. The follow-up phase will continue until 2035.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This is a follow-up observational study in Shanghai, China, that tracks residents enrolled in the STONE cohort since 2016–2017 to study cardiovascular-kidney-metabolic (CKM) syndrome — a cluster of conditions including heart disease, kidney disease, diabetes, and obesity that often occur together. The study re-examines these participants years later to understand how these conditions develop and interact over time. **You may be eligible if...** - You are one of the 4,094 residents originally enrolled in the STONE cohort between 2016 and 2017 - You completed the baseline questionnaire, physical exam, and clinical tests at that time - You are willing to participate in this follow-up study and can provide consent **You may NOT be eligible if...** - You have moved away from your original community for more than two years - You are no longer reachable through your original contact information - You are no longer alive or able to participate Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Shanghai Changzheng Hospital

Shanghai, Shanghai Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07043166


Related Trials